Archived Newsletters

31. 11.14.25 -- Is Passion A Criteria For Your CDMO Selection? 11/14/2025
    11/14/25 Outsourced Pharma Newsletter
32. 11.13.25 -- Navigating The Complexities Of Small Molecule Production With The Right CDMO Partner 11/13/2025

    11/13/25 Outsourced Pharma Newsletter

33. 11.13.25 -- Controlling Critical Quality Attributes In RNA Manufacturing 11/13/2025

    11/13/25 Outsourced Pharma Newsletter

34. 11.13.25 -- We're A Virtual Biotech. CDMOs Should Treat Us As A Priority 11/13/2025
    11/13/25 Outsourced Pharma Newsletter
35. 11.12.25 -- Solutions To Achieve Your Next AAV Gene Therapy Milestone With Confidence In Every Batch 11/12/2025

    11/12/25 Outsourced Pharma Newsletter

36. 11.12.25 -- Redefining API Manufacturing Through Continuous Innovation 11/12/2025

    11/12/25 Outsourced Pharma Newsletter

37. 11.12.25 -- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads 11/12/2025
    11/12/25 Outsourced Pharma Newsletter
38. 11.11.25 -- DNA-To-IND In Record Time? The Blueprint For Accelerating Biologics 11/11/2025

    11/11/25 Outsourced Pharma Newsletter

39. 11.11.25 -- Better Delivery, Better Outcomes: Simplifying Dosing With Nanoforming 11/11/2025

    11/11/25 Outsourced Pharma Newsletter

40. 11.11.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing 11/11/2025
    11/11/25 Outsourced Pharma Newsletter